Brugada syndrome and atrial fibrillation: Pathophysiology and genetics

Europace

Volumn 13, Issue 7, 2011, Pages 913-915

  Muggenthaler, Martina ^a   Behr, Elijah R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; QUINIDINE; SODIUM CHANNEL NAV1.5;

BRUGADA SYNDROME; CLINICAL FEATURE; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAM; GENETICS; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ATRIAL FIBRILLATION; BRUGADA SYNDROME; FEMALE; HUMANS; MALE; MUTATION; SODIUM CHANNELS;

EID: 79959704937     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur094     Document Type: Editorial

References (12)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. JACC 1992;20:1391-6.
2. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome; report of the Second Consensus Conference; endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70.
3. Yap YG, Behr ER, Camm AJ. Drug-induced Brugada syndrome. Europace 2009;11:989-94.
4. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. JACC 2008;52:1326-34.
5. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-73.
6. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S et al. Atrial fibrillation in patients with Brugada syndrome. J Am Coll Cardiol 2008;51:1169-75.
7. Bordachar P, Reuter S, Garrigue S, Cai X, Hocini M, Jais P et al. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 2004;25:879-84. (Pubitemid 38679948)
8. Pappone C, Radinovic A, Manguso F, Vicedomine G, Sala S, Sacco FM et al. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance. Eur Heart J 2009;30:2985-92.
9. Amin AS, Boink GJJ, Atrafi F, Spanjaart AM, Asghari-Roodsari A, Molenaar RJ et al. Facilatory and inhibitory effefcts of SCN5A mutations on atrial fibrillation in Brugada syndrome. Europace 2011;13:968-75.
10. Toh N, Morita H, Nagase S, Taniguchi M, Miura D, Nishii N et al. Atrial electrophysiological and structural remodelling in high-risk patients with Brugada syndrome: Assessment with electrophysiology and echocardiography. Heart Rhythm 2010;7:218-24.
11. Antzelevitch C. Brugada syndrome. PACE 2006;29:1130-59. (Pubitemid 44581402)
12. Yamada T, Yoshida Y, Tsuboi N, Murakami Y, Okada T, McElderry HT et al. Efficacy of pulmonary vein isolation in paroxysmal atrial fibrillation patients with a Brugada electrogram. Circ J 2008;72:281-6. (Pubitemid 351413369)